---
title: "Африка убита малярией"
date: 2021-06-11
draft: false
tags: "Общество"
geo: "Африке"
shorttext: "Корона в основном поражает пожилых людей. Прежде всего, малярия убивает детей - не здесь, а к югу от Сахары."
cover: "society"
lang: ru
---

Журналист и режиссер Катарина Вайнгартнер и ее команда потратили семь лет на исследование фильма "ДАС ФИБЕР" и опросили более ста экспертов. В фильме свое слово говорят те, кто убежден, что уже давно существует травяное средство и другие местные решения для профилактики и лечения малярии. Однако фармацевтическая промышленность и ВОЗ будут препятствовать применению. Телеканал SRF, который софинансировал фильм, отказывается его транслировать. Главный аргумент: Критикуемая фармацевтическая компания Novartis молчит. Вполне можно было бы транслировать дискуссию с Новартисом сразу после фильма.

#### Черные Жизни Не Имеют Значения?

Covid-19 привел мир к остановке, но малярийный паразит продолжает бушевать незаметно – год за годом: в результате блокировки из-за Covid-19 малярия убьет в два раза больше людей, чем обычно, по данным ВОЗ. Черные жизни не имеют значения? Малярия-древнейшая болезнь человечества. Она убила больше людей, чем все другие болезни и войны на Земле вместе взятые, и, вплоть до Covid-19, вероятно, была болезнью, в которую за последние десятилетия было вложено больше всего денег на исследования во всем мире. Тем не менее, паразиты малярии ежегодно убивают почти 500 000 человек в странах Африки к югу от Сахары, две трети из которых-дети.

#### Факты о малярии (источник: ВОЗ)

  - В 2018 году, по оценкам, во всем мире было зарегистрировано 228 миллионов случаев заболевания малярией.

  -По оценкам Всемирной организации здравоохранения (ВОЗ), число смертей от малярии в 2019 году составило 409 000. в 2021 году произойдет резкий рост из-за Covid 19.

  -Наибольшее число случаев заболевания малярией в 2019 году было зарегистрировано в африканском регионе Всемирной организации здравоохранения (ВОЗ) (213 миллионов или 93%), за которым следуют регион ВОЗ в Юго-Восточной Азии с 3,4% случаев и регион ВОЗ в Восточном Средиземноморье с 2,1%.

  -Дети в возрасте до 5 лет являются наиболее уязвимой группой; в 2018 году на них приходилось 67% всех смертей от малярии во всем мире.

  - На африканский регион ВОЗ приходится непропорционально большая доля глобального бремени малярии. В 2018 году в регионе было зарегистрировано 93% случаев заболевания малярией и 94% случаев смерти от малярии.

#### Ингредиенты из травы полыни

Представьте себе, если бы существовала трава, которая могла бы победить малярийного паразита и спасать тысячи жизней каждый день? Трава, которую любой может легко вырастить в саду?

В традиционной китайской медицине (ТКМ) Бейфусскраут, латинская артемизия, уже более 2000 лет является основным средством от малярии. в 1972 году китайский фармаколог Ту Юйю извлек активный ингредиент артемизинин из более чем 240 известных веществ полыни, латинского Artemisia annua. После успешных клинических испытаний, доказавших эффективность препарата, Китай предложил его ВОЗ в 1982 году в качестве решения для африканских регионов, где малярия ежегодно убивает сотни тысяч детей. ВОЗ отклонила это предложение.

Только 20 лет спустя европейские фармацевтические компании [запустили](https://www.unibas.ch/de/Aktuell/News/Uni-Research/Neuer-Malaria-Wirkstoff.html "Neuer Malaria-Wirkstoff zeigt vielversprechende Wirkung gegen resistente Malariaparasiten") ЗАКОН о комбинированной терапии артемизинином, который в 2001 году подписал 10-летний эксклюзивный контракт с Novartis на продажу этого ЗАКОНА на африканском континенте.  Торговое название - [Coartem](https://www.novartis.com/news/media-releases/novartis-malaria-treatment-coartem-80480mg-receives-who-prequalification-enabling-greater-access-patients "Novartis malaria treatment Coartem® 80/480mg receives WHO prequalification, enabling greater access for patients"). Между тем, коартем становится все менее и менее эффективным, потому что с годами сформировалось сопротивление.

Через 40 лет после его открытия Ту Юйю получил [Нобелевскую премию по медицине](https://www.nobelprize.org/prizes/medicine/2015/tu/biographical/ "Tu Youyou") в 2015 году.

#### Shock on site

During the seven-year biblical period needed to complete our film, we interviewed over 150 experts at conferences in the United States, China, Europe, and Africa. We researched at many scientific institutes worldwide, met activists and those affected.

What we then saw with our own eyes on the ground in clinics, villages and houses in Tanzania, Kenya and Uganda was shocking: outdated medicines, resistant parasites, failing health services, dying children and desperate parents who had to decide whether to spend their last money on food or medicine.

#### The main protagonists in the film

On our first trip to East Africa, we met our protagonists and immediately knew that they should be the focus of the film. People like Rehema Namyalo, a farmer, herbalist and single mother who runs a small clinic where she treats her patients with Artemisia and other herbs and shows them how to grow the plants themselves and use them to protect against malaria. The World Health Organization (WHO) still recommends banning the use of the whole medicinal plant. "They can't levy taxes on herbal medicine, so they import drugs like Coartem – everyone earns on it, including Uganda," Rehema explains a system she understands all too well.

{{< image_new picture="2021/042" title="Africa is killed by malaria" >}}

And people like doctor Richard Mukabana, an insect biologist at the University of Nairobi, who is tired of being used as a "field worker" for Western high-tech science institutes. He prefers to focus on the implementation of local, ecological solutions for vector control. Among other things, he also examines the role of community health work to reduce endemic malaria numbers near Lake Victoria. His experience: "There is always someone somewhere who is willing to make a profit from this disease. Usually it is not those who have the disease".  90 Percent of malaria research funds are spent in North America and Europe, while 90 percent of real cases of the disease occur in sub-Saharan Africa.

Ten years ago, pharmacologist Patrick Ogwang was able to prove with standard scientific methods that the Artemisia plant works as a tea for malaria prophylaxis. Obviously, the whole Plant is more effective. It acts as a tea, even if, like Ogwang, artemisinin is removed from the tea, that is, the ingredient that the WHO questions despite the lack of evidence. WHO and Novartis claim that the artemisinin in the plant has caused resistance in the parasites. This has never been proven.

Ogwang is relentlessly confronted with indifference or even resistance. Finally, he takes a critical position on the dominant role of the pharmaceutical industry and on the ever-increasing profits that companies derive from the treatment of malaria: "Do the pharmaceutical industry and WHO want another 30 million people to die before they can admit that the plant Artemisia also works?"

#### Novartis and WHO have no say

We decided to leave the usual suspects under the editing table. Those who constantly reveal their views on the so-called "poverty-related diseases" in the media anyway: scientists and philanthropic capitalists from the global North, as well as the people in the leadership positions of the pharmaceutical industry and the WHO, for the most part still white men.

In many documentaries, too, we experience the same repetition of old colonial patterns and narratives, in which Africa and African "suffering" serve only as a backdrop. The people affected by malaria in such films usually act exclusively as victims and, even worse, as statistics. Those affected are systematically rendered speechless and have neither access to their traditions, to drug production, to research funds, laboratories, nor to self-determined strategies.

That is why in the film "THE FEVER" the protagonists act as independent actors who spend their whole lives with the malaria parasites: They can and want to fight the malaria fever themselves – if they had the means and possibilities to do so.

#### Fear of lawsuits

When we presented this film concept with a rough cut to our co-producers and sponsors in Germany and Switzerland, we ran against an invisible but insurmountable wall. "If there is no white person from minute 33, we lose the German audience," said one producer. "Where is the objectivity? Where are the scientists?an editor complained, "Rehema Namyalo speaks of a perceived reality. Where are the facts?"She could not broadcast the film. "If we show this film, they will sue us," announced an editor and got out. By " man " was meant, in particular, Novartis.

The only institutions that were to our editorial decision-making, were the Austrian film promotion Fund and the ORF. Only with the mobilization of private loans could we finally complete the film. We did it. in 2019 we celebrated our premiere at the DOK Festival in Leipzig. The audience understood our film, and even the important Congolese Artemisia researcher Jerome Munyangi came from his exile in Paris to participate in our Q&A.

The news about the documentary has since spread, it has been shown at festivals and won many awards, e.g. at the Internazionale in Rome, from Oslo and Prague to Turkey, in Brazil and Taiwan, in Mexico, Spain, Canada and was to be shown at a festival in Guangzhou, where it unfortunately had to be withdrawn because of the "sensitive content". Most recently, the Film was banned in Uganda, but won the Festival in Zaragoza.

#### Covid-19 prevented proper film premiere

Due to Covid-19, a regular cinema release was not possible until now. At our online premiere in Germany for World Malaria Day 2021, 11,000 people wanted to watch online, which overwhelmed the server. However, it clearly showed how timely and correct it was to put the people of East Africa and their local problems and solutions in the foreground.

Our next goal is to send the Film on an Advocacy Tour in malaria-prone countries, along with the protagonist Rehema Namyalo and Artemisia afra seedlings (do not contain Artemisinin) and Ad-hoc Workshops. This is going to be a tough challenge. And maybe even a dangerous one. The censorship in Uganda shows us the extent of the resistance directed from Europe.

#### Alleged formation of resistance

Because the WHO and the pharmaceutical industry do not back away from their scientifically unproven argument that artemisinin in tea from Artemisia annua causes resistance in the malaria parasite, and they stubbornly reject any proposal to engage even in a scientific conversation on this topic and produce the necessary evidence. There has never been any scientific evidence that herbal preparations containing over 240 ingredients could cause resistance in any parasite. On the contrary, growing resistance of parasites to ACT was first documented in Southeast Asia, and now in African countries.

Evidence-based studies of recognized scientists-from Nobel laureate Tu Youyou to David Sullivan of Johns Hopkins University – conclude that the resistance is caused by the artemisinin in the ACT. While African research work is neglected or overlooked, WHO insists on banning Artemisia annua and does not support further studies on the subject.

In May 2020, in the face of the Covid-19 crisis, AFRO, the WHO Regional Office for Africa, issued a statement saying: "Medicinal plants such as Artemisia annua are being considered as possible treatments for Covid-19 and should be tested for efficacy and side effects."The WHO had never given malaria research this opportunity.

#### Scientific debate, provoke

Meanwhile, resistance against our film is organized. A hastily formulated petition full of errors, which has now been signed by 160 malaria researchers, tropical medicine institutes, doctors, lobbyists and pharmaceutical companies, has reached the last remaining broadcaster, the ORF. Nevertheless, the channel decided to broadcast the film. The petition accuses me as a director and all of us as a research and production team of unethical, manipulative and immoral methods. We would question the science and scientific evidence because we bring in African history and the African perspective that Artemisia tea works against malaria and does not cause parasite resistance. Our film is supposed to spark a scientific debate. But the petition calls for censorship of the film from the public television stations.

All the more we want to show our film in as many malaria-affected countries as possible. To this end, we founded the NGO Fight The Fever and are planning the first 30 screenings in East Africa in local languages later this year.

{{< youtube "_492RAjS828" >}}
